(3S)-3-Amino-azepane-1-carboxylic acid tert-butyl ester, 95.0%, 1g

3-(tert-Butyl)-5-iodo-1H-pyrazole, 95.0%, 250mg

5-Amino-1,3,4-oxadiazole-2-carboxylic acid ethyl ester, 99.0%, 25g

1-(tert-Butyl) 5-methyl (tert-butoxycarbonyl)-L-glutamate, 98%, 10g

2-(4-Chloro-3-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

3-Methyl-5-oxo-5H-thiazolo[3,2-a]pyrimidine-6-carboxylic acid, 95.0%, 250mg

5-Bromo-3-iodo-2-methoxypyridine, 95.0%, 1g

(-)-Terpinen-4-ol (contains 30% (+)-Terpinen-4-ol at maximum)>95.0%(GC)25mL

GC capillary column ROTI®Cap-FFAP, 25 m, 0.32 mm, 0.25 µm, 1 Piece(s)

Ethyl 5-chloro-1H-1,2,4-triazole-3-carboxylate, 95.0%, 5g

1-(2-Fluoro-3-methoxy-6-nitrophenyl)propan-2-one, 95.0%, 250mg

Methyl 2,5-dihydroxycinnamate, 97%, 10mg

Potassium trifluoro(morpholinomethyl)borate, 95%, 5g